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 Abstract 
 Background/Purpose: It has been substantiated that the quality of pleurodesis is reduced 
when non-steroidal anti-inflammatory drugs (NSAIDs) are used perioperatively. The effects 
of NSAID administration on the early inflammatory and fibrinolytic processes after mechani-
cal pleurodesis were investigated in an established pig model.  Methods: Left-sided mechan-
ical pleural abrasion was performed on 24 pigs assigned to either an NSAID or a control group. 
Pleural fluid and blood samples were analysed over a 24-hour period. Histological evaluation 
of neutrophil influx at the site of pleural abrasion was performed.  Results: The volume of 
pleural effusion was significantly decreased in the diclofenac group at 10 and 24 h, and the 
protein content was significantly lower. The diclofenac group at 24 h had a diminished total 
number of white blood cells and a reduced content of transforming growth factor-  . More-
over, the diclofenac group had a reduced percentage of neutrophils at 6 h. Significantly in-
creased levels of D-dimers and tissue plasminogen activator were measured at 6 h and of 
interleukin-10 at 24 h. Neutrophils at the site of pleural abrasion were significantly reduced. 
 Conclusions: Systemic application of diclofenac led to a local enhancement of fibrinolysis and 
attenuation of pro-inflammatory and fibrotic processes necessary for adhesion formation in 
our model.  Copyright © 2013 S. Karger AG, Basel 
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 Introduction 
 Video-assisted thoracic surgery (VATS) for mechanical pleurodesis is an established 
and reliable procedure for the treatment of recurrent spontaneous pneumothorax and of 
malignant pleural effusion. Non-steroidal anti-inflammatory drugs (NSAIDs) are being used 
with increasing frequency as systemic opioid-free analgesia due to their potent analgesic 
effects without having side effects on the central nervous system. It has been proven that 
the quality of adhesions formed 3 weeks after mechanical pleurodesis in a pig model is 
reduced when NSAIDs such as diclofenac are used perioperatively  [1] . Similar findings were 
also described after talc or silver nitrate pleurodesis in different animal models  [2] ; none-
theless, to our best knowledge no multicentre trial has been assigned to assess these exper-
imental observations. One hypothesis is that cyclo-oxygenase-2 (COX-2) inhibitors such as 
diclofenac inhibit the immediate postoperative inflammatory process necessary for pleural 
symphysis, due to their ability to suppress prostaglandin synthesis.
 However, the exact mechanism by which NSAIDs affect collagen deposition and the time 
course of the events leading to the formation of fibrin and of adhesions after pleurodesis 
have not been completely elucidated. The process of adhesion formation after a mechanic or 
toxic injury leads to the production and release of pro- and anti-inflammatory mediators by 
the local mesothelial cells. Another essential process during adhesion formation is the acti-
vation of the coagulation cascade  [3] .
 The aim of the underlying study was to clarify the following hypothesis: mediators of 
early pro- and anti-inflammatory as well as fibrinolytic processes are attenuated by periop-
erative diclofenac application in an established pig model of video-assisted thoracoscopic 
mechanical pleural abrasion.
 Materials and Methods 
 Animals 
 All animals were kept in the facility of the University Hospital Zürich. They had free access to 
standard laboratory pig chow and water in a temperature-controlled room with a 12-hour light/12-hour 
dark cycle with at least 10 days’ acclimation before experiments. The study was approved by our Institu-
tion’s Committee on Investigations involving animal subjects with the reference No. 142/2003. Animal 
care was provided in accordance with the Guide for the Care and Use of Laboratory Animals (National 
Institutes of Health NIH No. 86-23, revised, 1985) and in compliance with the European Convention on 
Animal Care.
 Study Design 
 24 pigs (Schweizerisches veredeltes Landschwein) with a mean weight of 32.8 kg (range 29.2–36.4 
kg) were randomly assigned to either a treatment group or a control group of 12 animals each. The exper-
iments were performed in 2 series. All animals of the first series (n = 12) did not remain under anaes-
thesia and survived 24 h until autopsy. Based on the preliminary results of the first series, we expected 
that the most relevant events leading to adhesion formation happened earlier than 24 h. Therefore, we 
chose a total observation period of 10 h, and in agreement with the veterinarian office all animals of the 
second series (n = 12) were maintained under anaesthesia. Surgeons performing VATS pleural abrasion 
and pathologists analysing specimens were blinded to the treatment. In the NSAID treatment group, 
animals received 50 mg diclofenac (Voltaren  ) orally twice a day beginning 2 days before the inter-
vention until autopsy. A total of 12 out of 24 animals received postoperative analgesia with a patch of 
fentanyl 75   g/h (Durogesic TTS  75   g/h). Gastric ulcer prophylaxis was applied with a selective 
blocker of the proton pump (omeprazole) 40 mg daily beginning 2 days before the operation. All drug 
dosages were the same as in our previous publication and correspond to the usual dosage in humans  [1] . 
Narcosis and unilateral left-sided apical mechanical pleural abrasion were performed by the use of the 
VATS technique as previously described  [1] . Pleural fluid (fluid recovered via a chest drainage) and blood 
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samples were collected at different time points in each animal. After a lethal intracardiac potassium 
injection under deep narcosis, the chest wall was excised, fixed in 4% paraformaldehyde and assessed 
for histopathological examination.
 Blood and Pleural Fluid Cytokine Determination 
 Blood samples were assessed 7 days before the operation, on the day of operation and 2, 4, 6, 8, 10, 17 
and 24 h postoperatively throughout a central venous catheter placed at the beginning of the operation 
under narcosis by preparation and cannulation of the left external jugular vein.
 The complete amount of the pleural fluid was harvested by aspiration via drainage at 6, 10 and 24 h 
postoperatively.
 For serum and plasma collection, a serum separator tube was used to collect serum, and the samples 
were clotted for 60 min at room temperature. For plasma, we used a 0.129 mol/l Na citrate separator tube. 
All blood samples were then centrifuged at 3,280 rpm in an Eppendorf 5810 R table centrifuge for 10 min 
at 4  °  C. Serum or plasma supernatants were collected and transferred in 15-ml sterile tubes and centri-
fuged at 4,000 rpm as above. Samples were alliquoted in sterile tubes and either assayed immediately 
(human tissue plasmin activator) or plunged in liquid nitrogen and stored at  ^  –80 °  C until use.
 White blood cells with percentage of neutrophils, platelets and D-dimers were quantified at the 
Institute of Haematology from the University Hospital Zürich. Cytokine levels either in pleural fluid, serum 
or plasma according to the parameter were measured by enzyme-linked immunosorbent assay (ELISA), 
according to the manufacturer’s protocols. The kits for porcine interleukin-1  (IL-1  ), porcine inter-
leukin-6 (IL-6), porcine interleukin-8 (IL-8), porcine interleukin-10 (IL-10) and porcine tumour necrosis 
factor-  (TNF-  ) were Duoset ELISA kits (Duoset, R & D Systems, Minneapolis, Minn., USA). The porcine 
transforming growth factor-  1 (isoform   1 , active form of TGF-  ) was analysed with a Quantikine ELISA 
(Quantikine, R&D Systems). The human tissue plasminogen activator activity assay (tPA) was from Inno-
vative Research (Southfield, Mich., USA).
 Histopathological Assessment 
 Formalin-fixed chest walls were decalcified with EDTA and stained with haematoxylin-eosin and 
elastin-van Gieson in predefined areas of pleural abrasion. A semiquantitative analysis of the neutrophil 
granulocytes in the pleura was assessed by a pathologist blinded to the treatment (P.V.) with the following 
semiquantitative score: 0 = no infiltration; 1 = scattered foci with some neutrophil granulocytes; 2 = 
several granulocytes; 3 = dense infiltration of granulocytes.
 Statistical Analysis 
 Sample size calculation was computed with the Windows program ‘nQuery Advisor’ Elasthoff, 1995. 
Statistical analysis was conducted using the SPSS software package for Windows (version 18.0; SPSS Inc., 
Chicago, Ill., USA). Data are expressed as means and standard deviations. Data were natural logarithm 
transformed if necessary to reach approximate normality. Non-parametric data are expressed as medians 
and 25–75% interquartile intervals. A repeated-measures analysis of variance was applied to test for a 
difference between the groups (characterized by the between-subjects effect) over the whole period of 
measurements. Student’s t tests were performed when data were normally distributed as post-hoc tests 
to compare both groups at some time points. A non-parametric analysis of variance (Mann-Whitney test) 
was applied for histological analysis. The data were expressed as medians  8 SD. p values smaller than 
0.05 were considered to be significant.
 Results 
 Analysis of the Pleural Fluid Parameters 
 The anti-inflammatory cytokine IL-10 was significantly increased after 10 h (31.41  8 
3.17 pg/ml) in the NSAID group in comparison to 26.43  8 1.8 pg/ml in the control group
(p  ^  0.05;  table 1 ;  fig. 1 ). The active fibrosis-inducing cytokine TGF-  1 24 h after pleural 
abrasion was significantly decreased in animals treated with the NSAID (1.99  8 0.38 pg/
ml) compared with the control group (2.99  8 0.64 pg/ml; p  ^  0.01;  table 1 ;  fig. 2 ). For the 
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fibrinolysis parameters, a significant increase in the fibrinolytic marker D-dimer was 
measured at 6 h in the NSAID group (11.64  8 6.34 mg/ml) in comparison to the control 
(5.24  8 1.03 mg/ml; p  ^  0.05;  table 1 ). For the cellular and biochemical parameters of the 
pleural fluid, NSAID treatment triggered a significant reduction in total cell numbers at 
24 h (7,850  8 2,268 cells/  l) when compared to the control group (20,420  8 9,144 
cells/  l; p  ^  0.01;  table 1 ). The percentage of neutrophils after NSAID treatment was also 
reduced (64  8 11%) in comparison to control (87  8 4.3%; p  ^  0.01;  table 1 ;  fig. 3 ) and 
this already 6 h after pleural abrasion. The volumes of pleural effusion collected in the 
NSAID groups at 10 h (9.33  8 6.68 ml) and 24 h (1.5  8 0.7 ml) were significantly lowered 
as compared with the control groups (21.83  8 10.38 ml, p  ^  0.03, and 67.5  8 3.53 ml,
p  ^  0.01, respectively;  table 1 ). Furthermore, the total level of protein decreased in the 
Table 1. C omparison of pleural fluid after mechanical pleurodesis with and without diclofenac
6 h 10 h 2 4 h
control NSAID control NSAID control NSAID
Cytokine and fibrinolysis parameters
IL-1, ng/ml 2.1680.73 2.0180.99 2.4780.36 2.4680.41 1.6380.90 1.2480.63
IL-6, ng/ml 4.3980.35 4.1380.48 4.4580.19 4.1080.37 4.0780.41 3.1981.27
IL-8, ng/ml 0.7380.61 0.8880.55 0.8080.86 0.6180.39 0.1580.21 0.1380.22
TNF-, pg/ml 98.84813.30 106.83823.75 83.06814.29 92.05813.04 91.57821.05 84.23824.15
IL-10, pg/ml 31.4883.25 34.2688.19 26.4381.8 31.4183.17b 28.485.86 21.2784.66b
TGF-1, pg/ml 3.3381.55 3.3482.83 4.5481.54 4.1882.83 2.9980.64 1.9980.38b
D-dimers, mg/ml 5.2481.03 11.6486.34b 4.1581.18 6.6883.03 4.8581.14 4.8180.60
tPA, fg/ml 193.3837 381.78186b 225.0838.1 403.38230 70.4858 87.1851
Pleural secretion parameters
Volume, ml 16.3385.64 20825.3 21.83810.38 9.3386.68a 67.583.53 1.580.70a
Cells/l 18,68087,738 14,80089,219 25,700821,113 8,42584,349 20,42089,144 7,85082,268a
Neutrophils, % 8784.3 64811b 75.5830.35 63.5825.47 82.66810.19 69.66833.52
Total protein, g/l 29.8382.31 28.6681.52 33.3382.87 18.5811.35a 36.582.12 28.7580.35a
Al l data are means 8 standard deviation. a p ≤ 0.05: comparisons of parameters; b p ≤ 0.05: comparisons of natural-loga-
rithm-transformed parameters.
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 Fig. 1. Box plots of IL-10 levels in 
the pleural fluid measured at dif-
ferent time points.  *  p  ^  0.05.
N = NSAID group; C = control 
group. 
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NSAID groups at both time points of 10 h (18.5  8 11.35 g/l) and 24 h (28.75  8 0.35 g/l) 
as compared with the control groups (33.33  8 2.87 g/l, p  ^  0.01, and 36.5  8 2.12 g/l,
p  ^  0.04, respectively;  table 1 ).
 We found only a small non-significant trend of the pro-inflammatory cytokines IL-1  
and IL-6 and the chemokine IL-8 to be reduced after NSAID treatment ( table 1 ).
 Analysis of the Blood Parameters 
 The anti-inflammatory cytokine IL-10 increased quickly until 6 h after pleural abrasion 
and levels were always higher in the NSAID group but not significantly in comparison to the 
control (not shown). Although TGF-  levels decreased from the time of operation until 
autopsy, evolution and comparison with the control group were not significant. The fibrino-
lysis parameter tPA exhibited a maximum plasma level 4 h after pleural abrasion in NSAID-
treated animals and was higher although not significantly different when compared with 
controls. Plasma levels of D-dimer in NSAID-treated animals significantly increased over 
0
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 Fig. 2. Box plots of active TGF-  1 
levels in the pleural fluid mea-
sured at different time points.
 *  p  ^  0.05. N = NSAID group; C = 
control group. 
 Fig. 3. Box plots of neutrophil 
levels in the pleural fluid mea-
sured at different time points.
 *  p  ^  0.05. N = NSAID group; C = 
control group. 
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time (p  ^  0.01), reached their maximum after 17 h, but the difference to the control group 
was not statistically significant.
 The pro-inflammatory chemokine IL-8 was significantly increased in the serum of the 
NSAID group during the first 10 h from a mean value of 192  8 35 pg/ml (2 h) to 151  8 35 
pg/ml (10 h; p  ^  0.03;  fig. 4 ). Since IL-8 induces chemotaxis of neutrophils, a permanently 
higher level of neutrophils in the serum was also measured over the first 10 h in the NSAID 
group in comparison to the control group (not shown). Nonetheless, this initial difference in 
the dynamics of IL-8 production during the first 10 h could not be significantly established 
comparing the two groups. The pro-inflammatory cytokines TNF-  , IL-6 and IL-1  did not 
significantly differ between both groups, although IL-6 and IL-1  levels were always lower 
in the group treated with the NSAID (not shown).
 We did not detect significant differences between all blood parameters measured in the 
NSAID or the control groups 7 days before the day of operation.
 Histopathological Analysis 
 Histological analysis after haematoxylin-eosin staining of the sites of pleural abrasion 
exhibited in the NSAID-treated group showed a significantly reduced number of neutrophils 
in comparison with the control group. The score value for the NSAID-treated group was 3.0 
 8 0.44 versus 1.0  8 0.44 in the control group (p  ^  0.01;  fig. 5 a, b).
 Discussion 
 The results of the study suggest that perioperative diclofenac application during VATS 
pleurodesis leads to modulations in anti- and pro-inflammatory as well as fibrinolytic 
processes during the first 24 h or early postoperative phase and confirm our previous obser-
vations of reduced adhesion 15 days after surgery  [1] .
 Diclofenac is considered a non-selective COX inhibitor but published evidence suggests 
that it is a predominant COX-2-inhibitor  [4] and modulates arachidonic acid levels in a variety 
0
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 Fig. 4. Scatter plots of IL-8 levels in the blood measured at different time points. N = NSAID group; C = con-
trol group. 
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of tissues. Arachidonic acid metabolites are synthesized by the cells present at the site of 
inflammation and mediate many aspects of postsurgical inflammation. As a result of 
personal observation by our group and others, the perioperative use of NSAIDs during pneu-
mothorax intervention was abandoned  [1] . The results of our previous experiments 
confirmed our suspicion  [1] and led us to assess, in the same model, the impact of the early 
postoperative processes. There is good evidence on the experimental level that the process 
of adhesion is hampered by the use of NSAIDs  [5, 6] . In a rabbit model, Liao et al.  [7] could 
establish that short-term administration of ketoprofen, a relative selective COX-1 inhibitor, 
does not decrease the effect of talc pleurodesis.
 In order to achieve a good pleurodesis for the treatment of pneumothorax and pleural 
effusion, an essential step is the appropriate release of mediators for inflammation and 
fibrosis produced by mesothelial cells. The panel of pro-inflammatory (IL-1, IL-6, IL-8 and 
TNF-  ) and anti-inflammatory cytokines (IL-10) we have chosen for analysis are liberated 
during the process of adhesion formation and induce further processes themselves such as 
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 Fig. 5.  a ,  b Representative hae-
matoxylin-eosin stainings of ani-
mals treated with NSAID (score 
0;  a , with only rare neutrophils 
in the tissue) in comparison to 
control (score 3;  b , with dense 
neutrophil infiltration in the tis-
sue, arrows). 
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neutrophil activation by the chemokine IL-8  [8] . Another essential mechanism during 
adhesion formation is the balance between the activation of the coagulation cascade and the 
fibrinolysis represented by tPA  [3] .
 The reduction of total protein in the pleural fluid is probably due to the fact that secretion 
of inflammatory proteins such as TGF-  , IL-6 and IL-1  is altered; a general trend of decrease 
in these proteins although insignificant – besides TGF-  – was described after NSAID 
treatment. Apart from this, TGF-  is known to be a potent inducer of pleurodesis  [9] , and 
elevated pleural fluid levels were measured in a rabbit model after talc pleurodesis  [10] . In 
our study, TGF-  was significantly reduced in the pleural fluid after mechanical pleurodesis 
and simultaneous treatment with diclofenac.
 In adhesion formation, TGF-  activates plasminogen activator inhibitor  [11] , and it 
interacts in its active form with the fibrinolytic system. Demonstration of failed talc 
pleurodesis was associated with increased pleural fibrinolysis  [12] . Therefore, in the 
presence of diclofenac, both reduced levels of TGF-  and increased levels of fibrinolysis 
factor D-dimer and human tPA in the pleural fluid may explain the reduced effect on 
pleurodesis described 3 weeks after thoracoscopic pleural abrasion  [1] .
 IL-8 has been shown to be an important chemokine in the development of acute pleural 
inflammation  [10] specifically as a chemotactic agent for neutrophils  [13, 14] . In our study 
we measured elevated IL-8 levels in the serum of diclofenac-treated animals and observed 
a trend for high neutrophil levels in the blood. Diclofenac is well described as an agent which 
induces L-selectin (CD62L) shedding from human neutrophils, and potentially reduces the 
extravasation of these cells in tissue  [15–17] . Moreover COX-2 inhibitors have been described 
to increase the levels of IL-8 by Wang et al.  [18] . In our case, the neutrophils recruited did 
not migrate properly to the inflamed pleural abrasion site. A high level of IL-8 chemokine in 
blood and an increased cleavage of L-selectin on neutrophils might have maintained the 
neutrophils in the blood stream. This limited local inflammatory response is also reflected 
by a significantly lower total cell number and lower percentage of neutrophils in the pleural 
fluid of diclofenac-treated animals. Additionally the histopathologically examined neutrophil 
influx at the site of pleural abrasion was significantly reduced.
 Although similarly altered anti-inflammatory and fibrinolytic processes present in the 
pleural fluid were also monitored in the blood, they were only for IL-8 levels significantly 
different between the groups. High levels of neutrophils in both blood (for NSAID-treated 
animals) and pleural fluid (for control animals) were generally associated with high levels 
of IL-8.
 We should also report some potential limitations of this study. Since the pig-specific 
ELISA kits were often near the detection limit declared by the manufacturer in the blood, 
this might be one reason why we could not measure significant differences in cytokine 
concentrations between the two groups. Another potential limitation might be a certain 
heterogeneity between the animals of the 2 series. Since diclofenac induces also dose-
dependent fluctuations of systemic cytokine levels, we should point out that the reported 
effects of diclofenac are also heterogeneous  [19–22] . This was particularly well documented 
for TNF-  levels where elevation is described after diclofenac treatment but is partially 
abolished in a dosage of 3 mg/kg body weight s.c.  [23] . These problems may be clarified in 
an epidemiological trial evaluating the rate of recurrence after mechanical pleurodesis and 
the use of NSAIDs  [24] .
 In conclusion, we validated that systemic application of diclofenac led to a local 
enhancement of fibrinolysis and attenuation of pro-inflammatory and fibrotic processes 
necessary for adhesion formation in an established pig model. These findings may explain 
the decreased success rate of pleurodesis after perioperative diclofenac treatment.
In clinical practice, we currently avoid the use of diclofenac as perioperative pain man-
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agement. Eventually, the use of COX-1 inhibitors such as ketoprofen according to the 
results of Liao et al.  [7] may be a solution for perioperative analgesia after pleurodesis 
operations.
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